Published 15 hours ago • loading... • Updated 15 hours ago

Boston Scientific announces pricing of €1.5 billion of senior notes

Boston Scientific Corporation announced a public offering of €850,000,000 of 3.000% notes due 2031 and €650,000,000 of 3.250% notes due 2034, which are fully guaranteed by the Company.
The offering will close on February 26, 2025, pending customary closing conditions.
Proceeds from the offering will help repay existing senior notes and be used for general corporate purposes, including short-term investments and working capital.
Boston Scientific advises that forward-looking statements may change based on economic conditions and other risks, urging readers not to rely excessively on such statements.

Insights by Ground AI

Does this summary seem wrong?

29 Articles

All

Left

Center

Right

The Sentinel

+27 Reposted by 27 other sources

Boston Scientific announces pricing of €1.5 billion of senior notes

MARLBOROUGH, Mass., Feb. 21, 2025 /PRNewswire/ -- Boston Scientific Corporation (the "Company") (NYSE: BSX) today announced that American Medical Systems Europe B.V. ("AMS Europe"), its wholly owned finance subsidiary, has priced a public offering of €850,000,000 aggregate principal amount of…

15 hours ago·Carlisle, United States

Read Full Article

stocktitan.net

Boston Scientific's €1.5B Euro Bond Sale: Key Terms and Strategic Impact Revealed

European subsidiary prices €850M and €650M notes at 3.000% and 3.250%, targeting debt refinancing and strategic investments. Closing expected February 2025.

15 hours ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year